Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin

Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin

Hepatitis C virus (HCV)-induced end-stage liver disease is the major indication for liver transplantation (LT). However, reinfection of the liver graft is still common, especially in patients with detectable viral load at the time of LT. Limited data are available on direct-acting antivirals in the...

Full description

Bibliographic Details
Main Authors: Tawar, Rajiv G., Heydmann, Laura, Bach, Charlotte, Schüttrumpf, Jörg, Chavan, Shailesh, King, Barnabas J., McClure, C. Patrick, Ball, Jonathan K., Pessaux, Patrick, Habersetzer, François, Bartenschlager, Ralf, Zeisel, Mirjam B., Baumert, Thomas
Format: Article
Published: Wiley 2016
Online Access:https://eprints.nottingham.ac.uk/42597/

Internet

https://eprints.nottingham.ac.uk/42597/

Similar Items